DARWIN EU® Overall survival in patients with locally advanced or metastatic non-small cell lung cancer treated with selected immunotherapies as first line of treatment

22/04/2024
23/06/2025
EU PAS number:
EUPAS1000000112
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

DARWIN EU_D2.2.3_Protocol_P2-C3-003_NSCLC_v3.2_Clean.pdf

English (884.56 KB - PDF) View document
Updated protocol

DARWIN EU_Protocol_P2-C3-003_NSCLC_V5_Amendment.pdf

First published: 17/09/2024
English (1014.16 KB - PDF) View document
Study results
Study report
Study report

DARWIN EU_Final Report_P2-C3-003_NSCLC_V5.pdf

English (2.84 MB - PDF) View document
Other information